Stoke Therapeutics, Inc.
STOK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001623526
In the last 90 days, Stoke Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 197 institutions reported holding it in 13F filings for Q2 2026, worth $2.49B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Stoke Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 92 | 105 | +13 |
| Shares | 43.1M | 42.3M | −800.0K (−1.9%) |
| Value | $569.4M | $544.4M | −$25.0M (−4.4%) |
New holders (20)
Institutions that held Stoke Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Avidity Partners Management LP | 891,100 | $11.4M | 0.25% |
| Baker Bros. Advisors LP | 369,327 | $4.74M | 0.03% |
| Sphera Funds Management Ltd. | 157,200 | $2.02M | 0.36% |
| Algert Global LLC | 79,948 | $1.03M | 0.06% |
| Gsa Capital Partners LLP | 75,127 | $965.0K | 0.13% |
| Man Group plc | 62,939 | $808.0K | 0.00% |
| HRT Financial LP | 59,319 | $761.0K | 0.01% |
| Teachers Retirement System of the State of Kentucky | 42,598 | $547.0K | 0.01% |
| D. E. Shaw & Co., Inc. | 26,135 | $336.0K | 0.00% |
| Marshall Wace, LLP | 20,617 | $265.0K | 0.00% |
| Jane Street Group, LLC | 17,327 | $222.0K | 0.00% |
| ExodusPoint Capital Management, LP | 15,702 | $202.0K | 0.00% |
| Virginia Retirement Systems Et Al | 15,200 | $195.2K | 0.00% |
| Balyasny Asset Management LLC | 11,430 | $147.0K | 0.00% |
| XTX Topco Ltd | 11,135 | $143.0K | 0.04% |
| Rafferty Asset Management, LLC | 11,047 | $142.0K | 0.00% |
| SG Americas Securities, LLC | 7,933 | $102.0K | 0.00% |
| UBS Group AG | 3,692 | $47.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 369 | $5.00K | 0.00% |
| Lindbrook Capital, LLC | 4 | $0 | 0.00% |
Sold out (7)
Institutions that held Stoke Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Federated Hermes, Inc. | 249,364 | $3.29M |
| Boothbay Fund Management, LLC | 205,463 | $2.71M |
| Ally Bridge Group (NY) LLC | 175,000 | $2.31M |
| Amitell Capital Pte Ltd | 64,807 | $856.0K |
| Altium Capital Management LP | 48,000 | $634.0K |
| Qube Research & Technologies Ltd | 27,158 | $359.0K |
| Group One Trading, L.P. | 200 | $3.00K |